|
US4036840A
(en)
*
|
1972-06-07 |
1977-07-19 |
Icn Pharmaceuticals |
2-Substituted-s-triazolo[1,5a]pyrimidines
|
|
PT100639A
(pt)
|
1991-06-27 |
1993-09-30 |
Univ Virginia Commonwealth |
Metodo para o tratamento terapeutico com compostos que sao ligandos ao receptor sigma e compostos ai utilizados, nomeadamente derivados fenilalquil-amina, aminotetralina,piperazina e piperidina
|
|
HUP0101810A3
(en)
|
1998-01-27 |
2002-05-28 |
Aventis Pharm Prod Inc |
Substituted oxoazaheterocyclyl factor xa inhibitors and pharmaceutical compositions containing them
|
|
US6194410B1
(en)
|
1998-03-11 |
2001-02-27 |
Hoffman-La Roche Inc. |
Pyrazolopyrimidine and pyrazolines and process for preparation thereof
|
|
US20040014744A1
(en)
|
2002-04-05 |
2004-01-22 |
Fortuna Haviv |
Substituted pyridines having antiangiogenic activity
|
|
EP1546103B1
(en)
|
2002-10-03 |
2009-03-18 |
Vertex Pharmaceuticals Incorporated |
Piperazine and piperidine derivatives for treatment of neurological diseases
|
|
US20070275961A1
(en)
|
2003-06-04 |
2007-11-29 |
Vernalis (Cambridge) Limited. |
Triazolo ' 1, 5-A ! Pyrimidines and Their Use in Medicine
|
|
CN100549014C
(zh)
|
2003-07-16 |
2009-10-14 |
詹森药业有限公司 |
作为糖原合酶激酶3抑制剂的三唑并嘧啶衍生物
|
|
KR20060105872A
(ko)
|
2003-12-29 |
2006-10-11 |
반유 세이야꾸 가부시끼가이샤 |
신규한 2-헤테로아릴 치환된 벤즈이미다졸 유도체
|
|
JP5149009B2
(ja)
|
2004-09-20 |
2013-02-20 |
ゼノン・ファーマシューティカルズ・インコーポレイテッド |
ヒトステアロイル−ＣｏＡデサチュラーゼを阻害するためのピリダジン誘導体
|
|
MX2007003325A
(es)
|
2004-09-20 |
2007-06-05 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso como inhibidores estearoil-coa-desaturasa.
|
|
EP1812439B2
(en)
|
2004-10-15 |
2017-12-06 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
US20100160349A1
(en)
*
|
2005-01-14 |
2010-06-24 |
Christopher John Love |
Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
|
|
US7507842B2
(en)
|
2005-08-12 |
2009-03-24 |
Radiorx, Inc. |
Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
|
|
WO2007113136A1
(de)
|
2006-03-30 |
2007-10-11 |
Basf Aktiengesellschaft |
Verwendung von substituierten riazolopyrimidinen zur bekämpfung von phyto pathogenen schadpilzen
|
|
JP2007332061A
(ja)
|
2006-06-14 |
2007-12-27 |
Nippon Kayaku Co Ltd |
新規ピラゾロ［１，５−ａ］ピリミジン誘導体及びその用途
|
|
US8153803B2
(en)
|
2006-07-18 |
2012-04-10 |
The General Hospital Corporation |
Compositions and methods for modulating sirtuin activity
|
|
WO2008048914A1
(en)
|
2006-10-17 |
2008-04-24 |
Boehringer Ingelheim International Gmbh |
Polycyclic compounds which modulate the cb2 receptor
|
|
AU2008275927B8
(en)
*
|
2007-07-18 |
2014-08-14 |
Janssen Pharmaceutica N.V. |
Sulfonamides as TRPM8 modulators
|
|
US8138168B1
(en)
|
2007-09-26 |
2012-03-20 |
Takeda Pharmaceutical Company Limited |
Renin inhibitors
|
|
GB0719803D0
(en)
|
2007-10-10 |
2007-11-21 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
|
CN101560212B
(zh)
*
|
2009-05-26 |
2011-03-16 |
华中师范大学 |
1,2,4-三唑并[1,5-a]嘧啶-2-乙基硫醚双取代衍生物的制备及其应用
|
|
WO2012080729A2
(en)
|
2010-12-14 |
2012-06-21 |
Electrophoretics Limited |
CASEIN KINASE 1δ (CK1δ) INHIBITORS
|
|
AP2013007070A0
(en)
|
2011-02-23 |
2013-08-31 |
Pfizer |
Imidazo[5,1-f][1,2,4] triazines for the treatment of neurological disorders
|
|
MX344600B
(es)
*
|
2011-06-27 |
2016-12-20 |
Janssen Pharmaceutica Nv |
Derivados de 1-aril-4-metil-[1,2,4]triazolo[4,3-a]quinoxalina.
|
|
CA2849726A1
(en)
|
2011-09-23 |
2013-03-28 |
Advinus Therapeutics Limited |
Amide compounds, compositions and applications thereof
|
|
CN103183675A
(zh)
*
|
2011-12-27 |
2013-07-03 |
山东轩竹医药科技有限公司 |
磷酸二酯酶-4抑制剂
|
|
US9034882B2
(en)
|
2012-03-05 |
2015-05-19 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
|
PL2834243T3
(pl)
|
2012-03-09 |
2018-09-28 |
Lexicon Pharmaceuticals, Inc. |
Związki na bazie pirazolo[1,5-a]pirymidyny, zawierające je kompozycje i sposoby ich zastosowania
|
|
US9193736B2
(en)
*
|
2013-06-11 |
2015-11-24 |
Janssen Pharmaceutica, Nv |
PDE 10a inhibitors for the treatment of type II diabetes
|
|
US9328095B2
(en)
*
|
2013-10-15 |
2016-05-03 |
Janssen Pharmaceutica Nv |
Heteroaryl linked quinolinyl modulators of RORgammat
|
|
WO2015130905A1
(en)
|
2014-02-27 |
2015-09-03 |
Merck Patent Gmbh |
Heterocyclic compounds as nav channel inhibitors and uses thereof
|
|
MX2016011784A
(es)
|
2014-03-19 |
2016-12-02 |
Boehringer Ingelheim Int |
Nuevos heteroarilos y su uso como medicamentos.
|
|
JP6626449B2
(ja)
|
2014-04-23 |
2019-12-25 |
ダート・ニューロサイエンス・（ケイマン）・リミテッド |
ＰＤＥ２阻害剤としての置換［１，２，４］トリアゾロ［１，５−ａ］ピリミジン−７−イル化合物
|
|
CN105566321B
(zh)
|
2014-10-29 |
2020-04-21 |
广东东阳光药业有限公司 |
杂芳化合物及其在药物中的应用
|
|
WO2016107602A1
(zh)
|
2015-01-01 |
2016-07-07 |
成都贝斯凯瑞生物科技有限公司 |
一类取代氮杂环衍生物及其应用
|
|
WO2016145614A1
(en)
|
2015-03-17 |
2016-09-22 |
Merck Sharp & Dohme Corp. |
Triazolyl pyrimidinone compounds as pde2 inhibitors
|
|
WO2017000276A1
(en)
|
2015-07-01 |
2017-01-05 |
Merck Sharp & Dohme Corp. |
Bicyclic heterocyclic compounds as pde2 inhibitors
|
|
WO2017000277A1
(en)
|
2015-07-01 |
2017-01-05 |
Merck Sharp & Dohme Corp. |
Substituted triazolo bicycliccompounds as pde2 inhibitors
|
|
WO2017066705A1
(en)
|
2015-10-14 |
2017-04-20 |
Aquinnah Pharmaceuticals, Inc. |
Compounds, compositions and methods of use against stress granules
|
|
HK1256751A1
(zh)
|
2015-11-02 |
2019-10-04 |
Janssen Pharmaceutica Nv |
[1，2，4]三唑并[1，5-a]嘧啶-7-基化合物
|
|
WO2017157882A1
(en)
|
2016-03-14 |
2017-09-21 |
Université Catholique de Louvain |
Serine biosynthetic pathway inhibitors
|
|
CN109937202B
(zh)
|
2016-11-02 |
2022-12-30 |
詹森药业有限公司 |
作为pde2抑制剂的[1,2,4]三唑并[1,5-a]嘧啶化合物
|
|
MA46690A
(fr)
|
2016-11-02 |
2019-09-11 |
Janssen Pharmaceutica Nv |
Composés de [1,2,4]triazolo [1,5-a]pyrimidine en tant qu'inhibiteurs de pde2
|
|
MY193511A
(en)
|
2016-11-02 |
2022-10-17 |
Janssen Pharmaceutica Nv |
[1,2,4]triazolo[1,5-a]pyrimidine derivatives as pde2 inhibitors
|
|
AU2017378182A1
(en)
|
2016-12-16 |
2019-06-06 |
Janssen Pharmaceutica Nv |
Bicyclic OGA inhibitor compounds
|